Glenmark Pharma Gets USFDA Form 483 for North Carolina Site—No Data Integrity Issues Found

Unknown Apr 02, 2026 800 Views

Glenmark Pharmaceuticals has confirmed that its Monroe, North Carolina facility was issued a Form 483 with five procedural observations following a recent inspection by the U.S. Food and Drug Administration (USFDA). The company clarified that none of the observations relate to data integrity, and...